biotech

Best-performing fund over five years

'Wobbling risk appetite'

Industry Voice: Biotech companies are increasingly pioneering groundbreaking therapies for diseases with high unmet medical need. Investing in these innovation leaders is a hallmark of BB Biotech'sinvestment philosophy.

Big sustainability challenges being tackled

Four types of asset categories

The healthcare sector has been under a black cloud since the US Presidential Election last year, driven by concerns over drug pricing.

Equity markets performed well in the first quarter driven by an expectation of lower corporate tax rates in the US and the potential repatriation of offshore cash and investments in infrastructure.

Which trusts were analyst favourites for the year?